AzTrials
AzTrials

Maternal DepressionTechMotherNCT02526355

Development and Assessment of a Mobile Phone Based Intervention to Reduce Maternal Depression and Improve Child Health

A study testing Mobile based intervention in people with Maternal Depression, run by Pakistan Institute of Living and Learning at 3 sites in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The prevalence rate of maternal depression in Pakistani women and its effect on the growth and development of young children and child mortality is very high. The main objective of this study is to increase access to evidence based psychological interventions for mothers who have children of age 0 to 30 months… Read more about this study

Who is it for?
Ages 18 to 44 years, women only
Conditions the study is for
Maternal Depression
What is being tested?
Mobile based intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
208 participants
Where
3 sitesPakistan
Study dates
Jan 2016to Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 44 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Mothers with mild to moderate depression will be included
  • Mother of children age 0-30months
  • The age range in the study is 18 to 44 years
  • Participants having mobile phones will be included

Who cannot join

  • Subjects will not be included if they had a diagnosed medical condition or significant physical or learning disability
  • Any form of psychosis, or are currently under psychiatric care.
  • Mothers with severe depression or suicidal ideation will not be included
  • Mothers who will be receiving any psychological intervention will be excluded
  • Mothers of children with any serious medical or psychiatric illness will also be excluded.

Trial locations and contacts

3 sites in 1 country.

Pakistan3 sites
  • Chiniot Maternity Hospital

    Karachi, Sindh

  • Sobhraj Maternity hospital

    Karachi, Sindh

  • Jinnah Hospital

    Lahore, Punjab Province, +92

Other trials in Pakistan

About this study

The prevalence rate of maternal depression in Pakistani women and its effect on the growth and development of young children and child mortality is very high.

The main objective of this study is to increase access to evidence based psychological interventions for mothers who have children of age 0 to 30 months, consistent with her values. The study will be a 2 (conditions) into 3 (Time) single blind randomized controlled trail. Depressed mothers will be randomized either to intervention arm or control arm. Intervention will include text messages based on Learning Through Play Plus (LTP plus CBT).

Read the detailed description

Disturbances in mother-infant relationship in depressed mothers negatively influence the child's development. There are a number of efficient treatments for postnatal depression including antidepressant medication, psychotherapy and psychosocial interventions. Tele-health and mobile health is a novel and emerging field in psychiatric and psychological care and treatment of mental health difficulties, it involves the use of telecommunications to provide health care, support and intervention from a distance.

The proposed study will test the efficacy of an innovative, affordable mobile based intervention program that can help mothers with postnatal depression in low resource countries such as Pakistan.

Participants will be recruited from maternal and child care centres in Karachi, Pakistan and those participants (n = 204) meeting inclusion criteria of the study will be randomized into one of the 2 treatment arms, i.e., intervention or control, after completion of baseline assessment. Intervention will be comprised of LTP Plus and will be delivered through text messages. Momentary Sampling assessment and Momentary Psychological intervention will be part of this study. Participants will be assessed again after completion of intervention (i.e., after 12 weeks) and then 3 months post intervention.

Being tested
Mobile based intervention
Keywords
Maternal depression, Mobile phone based intervention, Learning Through Play, CBT, Intelligent Real Time Therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mobile based interventionBehavioural

    Also called Intelligent Real Time Therapy iRTT

    Learning through Play Plus Intervention delivered through mobile phone

Study groups in NCT02526355
Study groupRoleWhat they receive
Mobile based InterventionExperimentalMobile based Intervention (Learning Through Play Plus) comprised of both LTP and CBT
Receives: Behavioral: Mobile based intervention
Waiting List ControlNo interventionWaiting List Control group will receive no intervention, but intervention will be offered to interested participants at the end of the study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Edinburgh Postnatal Depression Scale (EPDS)

    EPDS will be used to screen depression in mothers with child 0-30 months.

    Measured: change in scores from baseline to 3rd month and 6th month

Secondary outcomes (7)
  1. Patient Health Questionnaire (PHQ-9)

    PHQ-9 will be used to assess the severity of depression

    Measured: change in scores from baseline to 3rd month and 6th month

  2. EuroQoL-5 Dimensions (EQ-5D)

    EQ-5D will be used to assess the health related quality of life

    Measured: change in scores from baseline to 3rd month and 6th month

  3. Generalized Anxiety Disorder - 7 (GAD-7)

    GAD 7 will be used to assess severity of anxiety.

    Measured: change in scores from baseline to 3rd month and 6th month

  4. Knowledge of Expectation and Child Development

    25-item questionnaire will be used to assess maternal knowledge and expectations for child development in the first three years. Higher scores indicate better outcomes.

    Measured: change in scores from baseline to 3rd month and 6th month

  5. Clinical Interview Schedule Revised (CISR)

    The clinical Interview Schedule-Revised is a structured diagnostic instrument that was developed from the Clinical Interview Schedule (CIS), to assess psychiatric problems

    Measured: Change in scores from baseline to 3rd month and 6th month

  6. Assessment of the growth and development of children (Weight)

    Anthropometric measures of child growth will be collected through measuring children's weight in kilograms. weight and height will be combined to report BMI in kg/m^2

    Measured: Change in scores from Baseline and 6 month

  7. Assessment of the growth and development of children (Height)

    Anthropometric measures of child growth will be collected through measuring children height in meters. weight and height will be combined to report BMI in kg/m^2

    Measured: Change in scores from Baseline and 6 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Aug 2015 (estimated)
  2. Study startJan 2016
  3. Primary completionAug 2019
  4. Study completionAug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
208 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02526355
Sponsor's protocol ID
TechMotherCare001
Acronym
TechMother
Status last verified
Apr 2022
First submitted
15 Nov 2014
Last updated
25 Apr 2022
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Mobile based intervention in people with Maternal Depression, run by Pakistan Institute of Living and Learning at 3 sites in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Edinburgh Postnatal Depression Scale (EPDS) (time frame: change in scores from baseline to 3rd month and 6th month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in